N. Shesh

11.0k citations

283 papers · 7.6k indexed · 1 hit paper · h-index 45

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Pediatrics, Perinatology and Child Health top 0.5%
- Childhood Cancer Survivors' Quality of Life

Papers in

Cancer Research 55
- MicroRNA in disease regulation 22
- Cancer-related molecular mechanisms research 19
- Breast Cancer Treatment Studies 13
Statistics and Probability 26
- Statistical Methods in Clinical Trials 16

Co-authors: Jianmin Pan Susan Galandiuk Melissa M. Hudson Jane Carter Shelly Lensing Pamela S. Hinds Henry L. Roberts Aruni Bhatnagar
Journals: Journal of Clinical Oncology (17 papers)PLoS ONE (10 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)Pediatric Blood & Cancer (7 papers)Blood (6 papers)
Partner nations: United States India Canada

In The Last Decade

N. Shesh

271 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves 2016 · 511 citations

Peers

Replace Elisa T. Lee with:

Elisa T. Lee United States

Molin Wang United States

Mark R. Segal United States

N. E. Day United Kingdom

Gerard E. Dallal United States

Dario Consonni Italy

Thomas Scheike Denmark

John J. Spinelli Canada

Paul C. Lambert United Kingdom

Nicholas Day United Kingdom

N. Shesh relative to Elisa T. Lee United States Elisa T. Lee's profile →

Citations per field

00.5×2×3.0×

Elisa T. Lee · 1×

×3.0 1k/473

CR

×2.2 2k/711

PPCH

×2.2 318/146

SH

×1.2 527/428

HTM

×1.3 1k/764

ONCOL

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by N. Shesh

Since Specialization

Citations

This map shows the geographic impact of N. Shesh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Shesh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Shesh more than expected).

Fields of papers citing papers by N. Shesh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Shesh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Shesh. The network helps show where N. Shesh may publish in the future.

Co-authors

The 25 scholars most cited alongside N. Shesh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Shesh Line = papers co-authored together N. Shesh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Estimating transition intensity rate on interval-censored data using semi-parametric with EM algorithm approach Communication in Statistics- Theory and Methods ·Chen Qian, Deo Kumar Srivastava, Jianmin Pan, Melissa M. Hudson, N. Shesh	2023	1
2	Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination Vaccines ·Alok R. Amraotkar, Adrienne M. Bushau-Sprinkle, Rachel J. Keith, Krystal T. Hamorsky, Kenneth E. Palmer, Hong Gao, N. Shesh, Aruni Bhatnagar	2022	6
3	Five Years of Gene Networks Modeling in Single-cell RNA-sequencingStudies: Current Approaches and Outstanding Challenges Current Bioinformatics ·Samarendra Das, Upendra Kumar Pradhan, N. Shesh	2022	5
4	Associations Between Residential Exposure to Volatile Organic Compounds and Liver Injury Markers Toxicological Sciences ·Banrida Wahlang, Tyler C. Gripshover, Hong Gao, Tatiana Krivokhizhina, Rachel J. Keith, Israel D. Sithu, N. Shesh, Aruni Bhatnagar, Craig J. McClain, Sanjay Srivastava, Mathew C. Cave	2021	17
5	Dynamic alteration in miRNA and mRNA expression profiles at different stages of chronic arsenic exposure-induced carcinogenesis in a human cell culture model of skin cancer Archives of Toxicology ·Mayukh Banerjee, Ana P. Ferragut Cardoso, Laila Al‐Eryani, Jianmin Pan, Ted Kalbfleisch, Sudhir Srivastava, N. Shesh, J. Christopher States	2021	31
6	Analysis of Single-Cell RNA-Sequencing Data: A Step-by-Step Guide BioMedInformatics ·Aanchal Malhotra, Samarendra Das, N. Shesh	2021	4
7	Predictors of thrombosis in patients treated with bevacizumab SHILAP Revista de lepidopterología ·Jessica Sparks, Xiaoyong Wu, Mika Kessans Knable, N. Shesh, Vivek R. Sharma	2021	2
8	A Comprehensive Survey of Statistical Approaches for Differential Expression Analysis in Single-Cell RNA Sequencing Studies Genes ·Samarendra Das, Anil Rai, Michael L. Merchant, Matthew C. Cave, N. Shesh	2021	21
9	Financial Toxicity in Women With Breast Cancer Receiving Radiation Therapy: Final Results of a Prospective Observational Study Practical Radiation Oncology ·Mehran Yusuf, Jianmin Pan, N. Shesh, Harriet Eldredge-Hindy	2021	16
10	Impact of unequal censoring and insufficient follow-up on comparing survival outcomes: Applications to clinical studies Statistical Methods in Medical Research ·Deo Kumar Srivastava, E. Olusegun George, Zhaohua Lu, N. Shesh	2021	4
11	Circulating plasma microRNAs in colorectal neoplasia: A pilot study in assessing response to therapy Translational Oncology ·Stephen J. O’Brien, Uri Netz, Jacob Hallion, Campbell Bishop, Vincent Stephen, James Burton, Mason Paas, Kayla Feagins, Jianmin Pan, N. Shesh, Susan Galandiuk	2020	6
12	NHERF1 Loss Upregulates Enzymes of the Pentose Phosphate Pathway in Kidney Cortex Antioxidants ·Adrienne M. Bushau-Sprinkle, Michelle T. Barati, Kenneth B. Gagnon, Syed J. Khundmiri, Kathleen Kitterman, Bradford G. Hill, Amanda Sherwood, Michael L. Merchant, N. Shesh, Sudhir Srivastava, Barbara J. Clark, Leah J. Siskind, Michael E. Brier, Jessica Hata, Eleanor D. Lederer	2020	4
13	Adaptive Signature Design- review of the biomarker guided adaptive phase –III controlled design Contemporary Clinical Trials Communications ·Arinjita Bhattacharyya, N. Shesh	2019	8
14	Microbiome data analysis with applications to pre-clinical studies using QIIME2: Statistical considerations Genes & Diseases ·N. Shesh, Chen Qian, Jianmin Pan, P. Jayesh, Ming Song, Juhi Bagaitkar, Michael L. Merchant, Matthew C. Cave, Nejat K. Egilmez, Craig J. McClain	2019	41
15	Robust Estimation and Inference on Current Status Data with Applications to Phase IV Cancer Trial Journal of Modern Applied Statistical Methods ·Deo Kumar Srivastava, Liang Zhu, Melissa M. Hudson, Jianmin Pan, N. Shesh	2018	1
16	Evaluation of Classifier Performance for Multiclass Phenotype Discrimination in Untargeted Metabolomics Metabolites ·Patrick J. Trainor, Andrew P. DeFilippis, N. Shesh	2017	35
17	High-Dose Versus Weekly Cisplatin Definitive Chemoradiation Therapy for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma of the Head and Neck International Journal of Radiation OncologyBiologyPhysics ·Cesar A. Perez, Mark J. Amsbaugh, Wederson M. Claudino, Mehran Yusuf, Xiaoyong Wu, N. Shesh, Teresa L. Roberts, Liz Wilson, Lesley H. Volz, Sujita Khanal, A. Bennett Jenson, Elizabeth Cash, Jeffrey M. Bumpous, Craig L. Silverman, Paul Tennant, Neal Dunlap, Rebecca Redman	2016	1
18	Curcumin Implants, Not Curcumin Diet, Inhibit Estrogen-Induced Mammary Carcinogenesis in ACI Rats Cancer Prevention Research ·Shyam S. Bansal, Hina Kausar, Manicka V. Vadhanam, Srivani Ravoori, Jianmin Pan, N. Shesh, Ramesh C. Gupta	2014	10
19	Confidence Intervals for Survival Probabilities: A Comparison Study Communications in Statistics - Simulation and Computation ·Xiaobin Yuan, N. Shesh	2011	5
20	Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease Journal of Clinical Oncology ·Sarah S. Donaldson, Michael P. Link, Howard J. Weinstein, N. Shesh, S. Brain, Amy L. Billett, Craig A. Hurwitz, Matthew J. Krasin, Larry E. Kun, Karen Marcus, Nancy J. Tarbell, Jeffrey A. Young, Melissa M. Hudson	2007	86

About N. Shesh

N. Shesh is a scholar working on Cancer Research, Statistics and Probability, Oncology, Pediatrics, Perinatology and Child Health and Otorhinolaryngology, having authored 283 papers that have together received 7.6k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (31 papers), MicroRNA in disease regulation (22 papers), Gene expression and cancer classification (20 papers), Cancer-related molecular mechanisms research (19 papers), Statistical Methods in Clinical Trials (16 papers), Global Cancer Incidence and Screening (15 papers), Acute Lymphoblastic Leukemia research (15 papers) and Breast Cancer Treatment Studies (13 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pediatrics, Perinatology and Child Health (1.6k citations), Speech and Hearing (318 citations), Health, Toxicology and Mutagenesis (527 citations) and Oncology (1.0k citations). N. Shesh has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Jianmin Pan, Susan Galandiuk, Melissa M. Hudson, Jane Carter, Shelly Lensing, Pamela S. Hinds, Henry L. Roberts, Aruni Bhatnagar, Sean Phipps and M. Robert Eichenberger. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, International Journal of Radiation Oncology*Biology*Physics, Pediatric Blood & Cancer and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact